Agilent s Van Ingen Says New Microarray Apps a LSCA Driver | GenomeWeb

Chris van Ingen, the head of Agilent Technologies’ Life Sciences and Chemical Analysis business unit, told analysts Monday that there is a “resurgence” in DNA analysis based on microarray-based applications for comparative genomic hybridization and location analysis.

Microarray analysis of RNA is the larger part of the microarray market, where Agilent is considered the No. 2 player after dominant Affymetrix. It’s a market that is regarded as nearing maturity, with sales growth leveling off as whole-genome microarrays move toward near-commodity status.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."